Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Oncorena's new issue of shares fully subscribed
Contributed by:
PR Newswire
Tags
Oncorena-shares
More Like This
Oncorena receives FDA approval to initiate studies in the US
ONCOCLÍNICAS APPROVES R$ 1.5 BILLION CAPITAL INCREASE
European Organisation for Research and Treatment of Cancer & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer
Oncoinvent Announces First Patient Dosed in its Phase 2 Clinical Trial of Radspherin® in Ovarian Cancer Patients
Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer
Merus Announces Abstracts Accepted for Presentation at the ESMO Asia Congress 2023
Menarini Group Announces New Data on ORSERDU® (elacestrant) at the 2023 San Antonio Breast Cancer Symposium and on ELZONRIS® (tagraxofusp-erzs) at the 65th American Society of Hematology Annual Meeting and Exposition
How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options
